Literature DB >> 33646890

Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs-Cabell County, West Virginia, 2019.

Nathan W Furukawa1,2, Mathew Weimer3, Kara S Willenburg4, Michael E Kilkenny5, Amy D Atkins6, R Paul McClung1, Zachary Hansen3, Kathleen Napier5, Senad Handanagic1, Neal A Carnes1, Jeffrey Kemp Rinderle1, Robyn Neblett-Fanfair1, Alexandra M Oster1, Dawn K Smith1.   

Abstract

From January 1, 2018, through October 9, 2019, 82 HIV diagnoses occurred among people who inject drugs (PWID) in Cabell County, West Virginia. Increasing the use of HIV preexposure prophylaxis (PrEP) among PWID was one of the goals of a joint federal, state, and local response to this HIV outbreak. Through partnerships with the local health department, a federally qualified health center, and an academic medical system, we integrated PrEP into medication-assisted treatment, syringe services program, and primary health care settings. During the initial PrEP implementation period (April 18-May 17, 2019), 110 health care providers and administrators received PrEP training, the number of clinics offering PrEP increased from 2 to 15, and PrEP referrals were integrated with partner services, outreach, and testing activities. The number of people on PrEP increased from 15 in the 6 months before PrEP expansion to 127 in the 6 months after PrEP implementation. Lessons learned included the importance of implementing PrEP within existing health care services, integrating PrEP with other HIV prevention response activities, adapting training and material to fit the local context, and customizing care to meet the needs of PWID. The delivery of PrEP to PWID is challenging but complements other HIV prevention interventions. The expansion of PrEP in response to this HIV outbreak in Cabell County provides a framework for expanding PrEP in other outbreak and non-outbreak settings.

Entities:  

Keywords:  HIV; implementation; outbreak response; people who inject drugs; preexposure prophylaxis

Mesh:

Substances:

Year:  2021        PMID: 33646890      PMCID: PMC8721767          DOI: 10.1177/0033354921994202

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  19 in total

1.  Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale.

Authors:  Heather Bradley; Vicki Hogan; Christine Agnew-Brune; John Armstrong; Dawn Broussard; Kate Buchacz; Kenya Burton; Scott Cope; Erica Dawson; Gloria De La Garza; Anthony Gerard; Michael Granado; Rahul Gupta; Loretta Haddy; William Hoffman; Shacara D Johnson; Nathan Kirk; Chang Lee; Sheryl Lyss; Miguella Mark-Carew; Laura Quilter; Pamela Reynolds; Bridget Rose; Antoine Thompson; Lisa Varella; Paul Weidle; Brunilis White; David Wills; Sherri A Young; Brooke E Hoots
Journal:  Ann Epidemiol       Date:  2019-03-06       Impact factor: 3.797

2.  Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic.

Authors:  Andrea M Lerner; Anthony S Fauci
Journal:  JAMA       Date:  2019-09-17       Impact factor: 56.272

3.  Ending the HIV Epidemic: A Plan for the United States.

Authors:  Anthony S Fauci; Robert R Redfield; George Sigounas; Michael D Weahkee; Brett P Giroir
Journal:  JAMA       Date:  2019-03-05       Impact factor: 56.272

4.  Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Katherine C Smith; Brian Weir; Gregory M Lucas; Susan G Sherman; Suzanne M Grieb
Journal:  AIDS Behav       Date:  2020-06

5.  Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018.

Authors:  Charles Alpren; Erica L Dawson; Betsey John; Kevin Cranston; Nivedha Panneer; H Dawn Fukuda; Kathleen Roosevelt; R Monina Klevens; Janice Bryant; Philip J Peters; Sheryl B Lyss; William M Switzer; Amanda Burrage; Ashley Murray; Christine Agnew-Brune; Tracy Stiles; Paul McClung; Ellsworth M Campbell; Courtney Breen; Liisa M Randall; Sharoda Dasgupta; Shauna Onofrey; Danae Bixler; Kischa Hampton; Jenifer Leaf Jaeger; Katherine K Hsu; William Adih; Barry Callis; Linda R Goldman; Susie P Danner; Hongwei Jia; Matthew Tumpney; Amy Board; Catherine Brown; Alfred DeMaria; Kate Buchacz
Journal:  Am J Public Health       Date:  2019-11-14       Impact factor: 9.308

6.  County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

Authors:  Michelle M Van Handel; Charles E Rose; Elaine J Hallisey; Jessica L Kolling; Jon E Zibbell; Brian Lewis; Michele K Bohm; Christopher M Jones; Barry E Flanagan; Azfar-E-Alam Siddiqi; Kashif Iqbal; Andrew L Dent; Jonathan H Mermin; Eugene McCray; John W Ward; John T Brooks
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

7.  Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island.

Authors:  Meghan Peterson; Alexandria Macmadu; Ashley Q Truong; Josiah Rich; Kimberly Pognon; Mark Lurie; Jennifer G Clarke; Lauren Brinkley-Rubinstein
Journal:  J Subst Abuse Treat       Date:  2019-08-28

8.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

9.  Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.

Authors:  K B Biello; A R Bazzi; M J Mimiaga; D L Biancarelli; A Edeza; P Salhaney; E Childs; M L Drainoni
Journal:  Harm Reduct J       Date:  2018-11-12

10.  Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018.

Authors:  Norma S Harris; Anna Satcher Johnson; Ya-Lin A Huang; Dayle Kern; Paul Fulton; Dawn K Smith; Linda A Valleroy; H Irene Hall
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-12-06       Impact factor: 17.586

View more
  4 in total

1.  Communicating During an HIV Outbreak Among People Who Inject Drugs-West Virginia 2019.

Authors:  Meg Watson; Erica Thomasson; Elizabeth Adkins; Samantha Batdorf; Michael Kilkenny; Shelly Sikes Diaz; Laura Pegram; Jeffrey Kemp Rinderle; Michael LaFlam; Rachel Wingard; R Paul McClung; Alexandra M Oster; Jo Stryker
Journal:  AIDS Behav       Date:  2022-01-14

2.  Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.

Authors:  Hilary L Surratt; Hannah J Yeager; Akosua Adu; Evelyn A González; Elizabeth O Nelson; Tamara Walker
Journal:  Front Psychiatry       Date:  2022-05-30       Impact factor: 5.435

3.  Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.

Authors:  Adrian R King; Saanchi Shah; Laura A Randall; Paula M Frew; Anne Spaulding; Ian W Holloway
Journal:  BMC Infect Dis       Date:  2022-09-14       Impact factor: 3.667

4.  HIV Risk Among Urban and Suburban People Who Inject Drugs: Elevated Risk Among Fentanyl and Cocaine Injectors in Maryland.

Authors:  Ju Nyeong Park; Jill Owczarzak; Glenna Urquhart; Miles Morris; Noelle P Weicker; Saba Rouhani; Susan G Sherman
Journal:  AIDS Behav       Date:  2021-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.